M atrix metalloproteinases (MMP) are responsible for the degradation of various components of the extracellular matrix (ECM) as well as for processing of cell-surface receptors and adhesion molecules. A strict regulation of these enzymes represents an important mechanism in homeostasis. Most MMP are upregulated after damage to the epidermis or in diseased skin (Okada et al, 1997; Madlener, 1998; Parks et al, 1998) . Together with serine proteases, MMP are involved in wound healing and rebuilding of the epidermal barrier that protects the body against pathogens . Accordingly, it has been shown that wound healing was delayed in mice treated with an MMP-speci¢c inhibitor. Also, mice de¢cient for stromelysin 1 (MMP-3) (Agren et al, 2001 ) exhibited a retarded wound healing, although reepithelialization appeared normal (Bullard et al, 1999) . In contrast, the overexpression of MMP-1 in a transgenic mouse model also led to a delay in wound healing (Di Colandrea et al, 1998) .
During wound healing and in in£ammatory processes, MMP are responsible for the processing of basal membrane components such as collagen type IV, laminin 5, nidogen, and proteins of the provisional wound bed, for example, ¢brin, ¢bronectin, and collagen type I (Parks et al, 1998) . Another aspect that emerged more recently is the involvement of MMP in the regulation of local homeostasis by the release of growth factors and cytokines from their extracellular stores, their processing, or the processing of their receptors. Thus, TGF-b is activated by MT1-MMP and MMP-9. MMP-9 can also increase the activity of interleukin (IL)-8 through an N-terminal processing that enhances the proliferation of various cells in the skin (Van den Steen et al, 2000; Mu et al, 2002) .
Microbial infections as well as psoriasis are accompanied by an in£ammation and a dysregulation of epidermal proliferation and di¡erentiation. The regulation and the role of most of the MMP in cutaneous infections have not yet been delineated, although MMP produced in the skin are able to degrade virtually all ECM components. Increased degradation of ECM proteins could therefore facilitate the dissemination of pathogens. Thus, human bronchial epithelial cells upregulate both gelatinases upon stimulation with lipopolysaccharide (LPS). In addition, chlamydial HSP60 positively regulates the expression of gelatinases in macrophages (Yao et al, 1996; Kol et al, 1998) . Furthermore, phospholipase C, a putative virulence factor of several pathogenic bacteria, appears to increase the expression of gelatinase B and stromelysin 1 in epithelial cells (Firth et al, 1997) .
In this study, we have characterized the epidermal expression of the recently cloned MMP-19 (Cossins et al, 1996; Penda Ł s et al, 1997; Sedlacek et al, 1998) . This study also complements the study of Impola et al (2003) , who reported the expression of MMP-19 in malignant epidermal tumors and various wounds. We found that MMP-19 was typically expressed in basal keratinocytes of the intact healthy epidermis but was dysregulated in psoriasis as well as in eczema and tinea. Generally, its expression correlated with that of cytokeratin 14 and can be downregulated by retinoic acid (RA) and dexamethasone (Dex). A signi¢cant upregulation of MMP-19 appears upon contact of keratinocytes with type I collagen.
MATERIALS AND METHODS
Antibody preparation For immunostaining, a new monoclonal antibody was prepared. Its immunoreactivity was compared with the a⁄nity-puri¢ed polyclonal rabbit anti-MMP-19 antibodies designated anti-Pep21. These latter antibodies were prepared as described previously by immunization of rabbits with the KHL-coupled peptide and recognize a unique 21-amino-acid peptide derived from the hinge region (Sedlacek et al, 1998) . The monoclonal antibody CK8/4 was prepared by immunization of a mouse with the full-length human MMP-19. The selected antibody CK8/4 recognizes speci¢cally the propeptide domain, as determined by immunoblotting of MMP-19 constructs representing its individual domains and by ELISA against the prodomain-derived peptide NH 2 -LQKPLEGSNNFKPDITEALRAFQEASEL. Further analysis with synthetic peptides has shown that the CK8/4 does not cross-react with other known MMP. The antibody was puri¢ed from culture supernatants using protein A^Sepharose (Pharmacia, Germany).
Cell culture and transfection The HaCaT keratinocyte cell line was generously provided by N. Fusenig (DKFZ, Heidelberg, Germany). Cells were maintained at 371C in a humidi¢ed atmosphere of 5% CO 2 in Dulbecco's modi¢ed Eagle's medium (PAA, Linz, Austria) supplemented with 10% fetal calf serum, 50 units per mL penicillin, and 50 mg per mL streptomycin. For the regulation studies, cells were cultured in Dulbecco's modi¢ed Eagle's medium with 0.5% fetal calf serum and stimulated with the following compounds at given concentrations: tumor necrosis factor-a (TNF-a; 1.0 and 10 ng/mL; donated by D. Adam, Kiel, Germany), IL-15 (20 ng/mL; donated by R. Rˇckert, Borstel, Germany), IL-8 (10, 50, and 100 ng/mL; Sigma Aldrich), native regulated on activation normal T cells expressed and secreted (RANTES, 10 and 100 ng/mL, donated by J.-M. Schr˛der Kiel, Germany), IL-6 (0.1, 1.0, and 10 pg/mL, donated by S. Rose-John, Kiel, Germany), LPS, and lipoteichoic acid (LTA; 1, 5, and 10 mg/mL; Sigma Aldrich). Type I and type IV collagen (BD Biosciences, Bedford, MA) were coated in concentrations 5 and 10 mg per cm 2 , respectively, on a microtiter plate.
The full-length cDNA of human MMP-19 was subcloned into pIRES2-EGFP (Clontech, Paolo Alto, CA), hereafter referred to as pIRES-MMP19WT. HaCaT keratinocytes were transfected with the FuGENE 6 transfection reagent according to the manufacturer's instructions (Roche, Mannheim, Germany), and stable cell lines were selected in 0.6 mg per mL G418.
Foreskin for isolation of primary keratinocytes was donated by R. Paus (Hamburg, Germany). These keratinocytes were cultured for 48 h in K-SFM medium (Gibco, Invitrogen Corp., Carlsbad, CA) on monomeric type I collagen medium containing either 0.05 or 1.2 mM CaCl 2 or 0.05 mM CaCl 2 plus 20 ng per mL TGF-a (Promocell GmbH, Heidelberg, Germany).
Promoter activity The regulation of the promoter of MMP-19 was studied using the dual-luciferase assay (Promega, Madison, WI) and with the vector construct containing the 1898-bp stretch of the 5 0 -£anking region (^1898/LUC) as described previously (Mueller et al, 2000) . Brie£y, 5 Â10
4 HaCaT cells per well cells were transfected with^1898/LUC construct using the Fugene 6 (Roche) in the serum-free K-SFM medium (Gibco, Invitrogen Corp.) containing 0.03 mM CaCl 2 . Twenty-four hours after each transfection assay, the media were replaced with serum-free K-SFM medium (Gibco, Invitrogen Corp.) containing 0.03 mM CaCl 2 and one of the following compounds: Dex (10, 1, and 0,1 mmol; Sigma Aldrich), RA (10, 1, and 0.1 mmol; Sigma Aldrich), phorbol myristate acetate (PMA, 0.1 mM; Sigma Aldrich), IL-6 (1 ng/mL), IL-8 (200 ng/mL), TNF-a (100 ng/mL), and TGF-b (10 ng/mL). Cells were cotransfected with pRL-TK renilla luciferase vector (Promega) as an internal control, as described above. Forty-eight hours after transfection, the cells were washed and lyzed, and luminescence was measured according to the manufacturer's manual (Promega) using a single-sample luminometer (TD/20, Turner Design, Sunnyvale, CA). All assays were performed in duplicate in three separate experiments. The means of these duplicates were taken to obtain the relative luciferase activity, which is expressed in relative light units as de¢ned by the ratio of ¢re£y to renilla luciferase activity multiplied by the factor 10 4 . Data are presented as means7SEM and show the percentage of relative light units change against the control (without the stimulatory/inhibitory compound). Results were analyzed using one-way ANOVA with Tukey's multiple comparison post test.
Immunostaining Tissue specimens embedded in para⁄n were sectioned to 3 -mm thickness, depara⁄nized, and incubated in 3% H 2 O 2 to block endogenous peroxidase activity. Antigen retrieval was performed by treating sections with 10 mM citric acid, pH 6.0 at 901C for 30 min. After being washed in 5 mM Tris^HCl bu¡er containing 150 mM NaCl, pH 7.3 (TBS), sections were digested with 0.1% trypsin in TBS for 10 min at 371C and then blocked with normal serum, which was prepared from the species in which the secondary antibody was produced. To detect MMP-19, both the monoclonal anti-MMP-19 antibody CK8/4 and the polyclonal a⁄nity-puri¢ed rabbit anti-pep21 were used. Basal keratinocytes were identi¢ed with monoclonal anti-cytokeratin 14 antibody (ICN, Irvine, CA). Bound antibodies were detected using the Vectastain ABC Elite kit (Vector Laboratories, Burlingame, CA) following the manufacturer's instructions. Peroxidase activity was detected using 3 -amino-9-ethylcarbazole as a chromogenic substrate (Vector Laboratories). Sections were counterstained with hematoxylin. The speci¢city of the staining was proved with an IgG1 control antibody (not shown).
For immuno£uorescent detection, human skin was embedded in Jung tissue freezing medium (Leica Instruments, Nussloch, Germany), snapfrozen in liquid nitrogen, and cut to a thickness of 3 mm. The sections were air-dried and ¢xed in acetone for 30 s, after which they were blocked with Powerblock (Biogenex, San Ramon, CA) and incubated with the primary antibody (CK8/4 diluted to 1:100) in phosphate-bu¡ered saline/Triton X-100 (0.1%) containing 3% bovine serum albumin for 2 h at room temperature. Bound antibodies were detected with Alexa 488-conjugated goat anti-mouse IgG antibody (Molecular Probes, Eugene, OR). The sections were ¢nally mounted using EUKITT (O. Kindler GmbH & Co, Freiburg, Germany). Images were taken from 8 to 12 representative sections of a tissue sample and were captured by a video camera (Sony, Japan) mounted on an Olympus BX-500 £uorescent microscope. Images were processed with the Analysis Soft Imaging system (Lakewood, CA).
Immunoblotting and gelatin zymography HaCaT cells were scraped from the tissue culture vessel into ice-cold phosphate-bu¡ered saline, pelleted by centrifugation, and then lyzed for 45 min on ice in 10 mM Tris^HCl bu¡er containing 1 mM EDTA, 150 mM NaCl, 1% Triton X-100, pH 7.5, Complete proteinase inhibitor (Roche, Germany). The amount of protein in the samples was determined using the BCA protein assay (Pierce, Rockford, IL). Proteins in the culture medium of HaCaT cells were concentrated by the addition of 4 vol of ice-cold acetone. Equal amounts of proteins were separated by SDS^PAGE, followed by electrophoretic transfer onto a nitrocellulose membrane (Schleicher & Schuell, Germany) . Membranes were blocked with 3% milk in TNT bu¡er containing 20 mM Tris-HCl, 500 mM NaCl, and 0.05% Tween 20, pH 7.5. MMP-19 was detected with the following antibodies: a⁄nity-puri¢ed polyclonal anti-MMP-19 (anti-pep21) antibodies prepared as described, monoclonal antibody CK8/4, or polyclonal a⁄nity-puri¢ed anti-MMP-19 (Chemicon, Temecula, CA). Staining with monoclonal antibodies against cytokeratin 14 (Cappel/ICN, Aurora, OH) and Ki67 (Dako, Hamburg, Germany) was used to correlate the staining pattern of MMP-19. For immunoblotting, the purchased anti-MMP19 antibodies (Chemicon) were preferred because they better re£ected the quantitative di¡erences than the other two antibodies.
Primary antibodies were diluted 1:1000 in 2% milk in TNT bu¡er. The bound antibodies were detected using peroxidase-conjugated goat antirabbit and anti-mouse IgG antibodies (Pierce, Rockford, IL) and the chemiluminescence luminol reagent (Santa Cruz Biotechnology, Santa Cruz, CA). Signals were recorded with a luminescent image analyzer (FujiFilm, Tokyo, Japan).
For zymography, conditioned media standardized for cell number were mixed with a nonreducing SDS sample bu¡er and loaded onto 8% polyacrylamide gels containing 1 mg per mL gelatin. After electrophoresis, the gels were soaked in 2.5% Triton X-100 to remove the SDS. Gelatinolytic activities were developed in 50 mM Tris-HCl bu¡er containing 5 mM CaCl 2 , and 0.05% Triton X-100, pH 7.5 at 371C for 24 h. Lytic bands were visualized by staining the gels with Coomassie brilliant blue R-250 and destaining in 10% acetic acid.
Immunoprecipitation For detection of secreted MMP-19, keratinocytes were labeled overnight with 50 mCi per mL [ 35 S]methionine/cysteine. Media were collected, centrifuged to discard cellular debris, and incubated with 50 mL per mL Pansorbin (Calbiochem, San Diego, CA) for 1 h at 41C.
After centrifugation, antibodies against MMP-19 (Chemicon) were added to a ¢nal concentration of 2 mg per mL, followed by overnight incubation at 41C. After the addition of protein G^Sepharose, and an additional incubation for 1 h at 41C, the precipitates were washed three times with cold Tris bu¡er (10 mM Tris, 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100, pH 7.4). Precipitates were boiled in Laemmli bu¡er and separated on 10% SDS^polyacrylamide gels under reducing conditions. Gels were ¢xed, incubated for 30 min in Amplify £uorographic reagent (Amersham Pharmacia Biotech, Freiburg, Germany), dried, and exposed to X-ray ¢lms.
Clinical material Formalin-¢xed, para⁄n-embedded samples of skin derived from 21 patients with ages ranging between 16 and 65 years were obtained from the Department of Dermatology, University of Kiel, Germany, with the approval of the Regional Board of the Medical Ethics Commission. Healthy tissue was obtained from patients, aged between 16 and 25 years, undergoing surgical procedure for skin tumors. (n ¼ 3). Skin specimens included eczema (n ¼ 7), tinea corporis (n ¼ 7), and psoriasis (n ¼ 7). To study activation of MMP-19 in psoriatic lesions and healthy skin, biopsies were obtained from patients with plaque type psoriasis (n ¼ 3). Biopsies from healthy skin area of the same patients were used as controls. For immuno£uorescence staining, tissue was also obtained from patients (n ¼ 3) undergoing surgery for the removal cancerous skin. These samples were stored in Dulbecco's modi¢ed Eagle's medium for 2^3 h until their processing for cryosectioning.
RESULTS
Expression of MMP-19 in a healthy epidermis In the healthy human skin, the staining for MMP-19 was generally restricted to the basal epidermal layer. Suprabasal and di¡erentiated keratinocytes did not show immunoreactivity to MMP-19 (Fig 1a,b) . The expression pattern of MMP-19 correlated with the expression of cytokeratin 14 that represents a marker for undi¡erentiated basal keratinocytes. It appeared that the MMP-19 expression was polarized in the basal keratinocytes: most of the immunoreactivity was localized to the basal side of the cells (Fig 1b) . In healthy skin, dermal ¢broblasts and other cells resident in the dermis were not stained with any of the antibodies used in this study. Hair follicles and glands In hair follicles the anti-MMP-19 immunoreactivity was mostly found in cells within the outer root sheet and corresponded with the cytokeratin 14 staining (not shown). This could be seen in the transverse sections of terminal hair follicles (Fig 1h,i) of the anagen stage. Both antibodies used to identify MMP-19 expression showed a very similar staining pattern in the outer root sheet. Cells in the inner root sheet and the connective tissue sheet were stained weakly with both antibodies. The capillaries that nourish the connective sheet expressed MMP-19 as well. Strong immunoreactivity could also be seen in the section of the middle of the terminal hair follicle of the postanagen phase (inner root sheet is missing ; Fig 1f,g ). The hair follicle is surrounded by sebaceous glands where MMP-19 was expressed by the cells of the secretory epithelium, mostly by undi¡erentiated cells in proximity of the gland capsule (Fig 1d,f,g ). In eccrine sweat glands, there was a di¡use staining of the entire duct wall as well as of the basal and luminal layers. Nevertheless, the normal eccrine glands displayed considerable variations in staining, ranging from a negative to an intense reaction (Fig 1d,e) .
Expression of MMP-19 in blood vessels In the normal healthy skin MMP-19 was typically not expressed in endothelial cells of larger blood vessels (not shown). Nevertheless, capillaries, which nourish hair follicles and various glands, appeared to express MMP-19 (Fig 1c,e ,f,h, arrowheads). Endothelial cells in lymphatic vessels were also stained with the anti-MMP-19 antibodies (Fig 1n,o) . Furthermore, blood vessels in triads that contain an artery, a vein, and a nerve, expressed MMP-19 in both endothelial cells and smooth muscle cells (Fig 1j,k) . Smooth muscle cells in the arterioles were usually stained moderately. In the a¡ected areas of various skin diseases, the staining for MMP-19 in blood vessels was obvious. Especially in areas with a large in¢ltration of in£ammatory cells, almost all capillaries, venules, and arterioles (Fig 1i,m) were stained.
Dysregulation of MMP-19 during epidermal diseases In eczema MMP-19 immunostaining was not con¢ned to the stratum basale but extends to the lower to middle spinous layers (Fig 2a) . This correlated with cytokeratin 14 whose expression was also dysregulated in the same manner (Fig 2b) . Typically, large dermal in¢ltration of in£ammatory cells were observed beneath the area in which the epidermal expression of MMP-19 was dysregulated.
In tinea corporis an extended staining for MMP-19 was visible in the basal and the entire spinous layers (Fig 2c) . The staining pattern of cytokeratin 14 was similar and involved the basal and the lower half of the spinous layers (Fig 2d) . Compared to the eczema, the dysregulation of MMP-19 as well as cytokeratin 14 was not necessarily accompanied by the in¢ltration of in£ammatory cells in the dermis. In psoriasis staining with anti-MMP-19 antibodies, the polyclonal a⁄nity-puri¢ed anti-Pep21 (Fig 2e) , and the monoclonal CK8/4 (Fig 2f) antibodies revealed obvious expression of MMP-19 in the basal layer in the papillae (rete ridges) and arcades (Fig 2e,f) . Moreover, the staining for MMP-19 was extended to the suprabasal layers at the rete ridges and also irregularly to suprabasal and spinous keratinocytes in the ridges (Fig 2e) . The antibodies recognizing the hinge region of MMP-19 (anti-Pep21; Sedlacek et al, 1998) showed a staining pattern corresponding to that of the CK8/4 antibody, although upper spinous layers were stained more intensively. This small di¡erence most likely re£ects the processing of MMP-19. The monoclonal antibody CK8/4 that are directed against the propeptide domain cannot recognize the processed form of MMP-19 without this domain (Mauch et al, 2002) . The most intensive staining was found in basal layers, as with the CK8/4, and in upper spinous layers. The staining for MMP-19 in the basal and higher spinous layers correlated with the presence of cytokeratin 14 (Fig 2g) . The staining also correlated with the proliferation marker Ki67 in the basal and suprabasal layers of rete ridges and also partially in the arcades. Nevertheless, no correlation was observed in the upper spinous layers (Fig 2h) .
Because the expression of MMP-19 appeared to be dysregulated in the psoriatic lesions, we tried to elucidate whether MMP-19 is di¡erentially processed in the diseased area. Small biopsies from psoriatic lesions and healthy skin of the same patient were analyzed by immunoblotting with antibodies recognizing the propeptide domain and hinge region of MMP-19. Thus, we were able to di¡erentiate between the processed, probably active, and unprocessed forms of this enzyme. Using both antibodies, we could identify the unprocessed glycosylated form of 70 kDa. The band representing this form was considerably weaker in the psoriatic lesions (Fig 2i) than in healthy skin. In contrast, MMP-19 in the psoriatic lesions, stained with anti-hinge antibodies, appeared to be converted into a processed form (glycosylated) that seems to be predominant and may represent active MMP-19 (Fig 2, left  panel) . Thus, MMP-19 is not only upregulated in psoriatic lesions but appears most likely in an active, processed form.
Regulation of MMP-19 in HaCaT keratinocytes
Because the expression of MMP-19 was dysregulated in the diseased areas studied, we analyzed which compounds, including cytokines and chemokines, in£uence the expression of MMP-19 in the cell line HaCaT and in primary keratinocytes. We also compared the protein expression with the activity of the MMP-19 promoter.
HaCaT cells express endogenous MMP-19 without additional cytokine stimulation and thus resemble the basal keratinocytes that express MMP-19 constitutively. TNF-a and IL-6 are proin£ammatory cytokines that are upregulated in various pathologic situations and are involved in wound healing, psoriasis, and in£ammation. Both cytokines are known to upregulate several MMP. Nevertheless, MMP-19 expression was not a¡ected either at the protein or at the transcriptional level, as can be seen from the promoter activity assays (Fig 3a,e) . In contrast, the expression of MMP-9 (gelatinase B) was induced by TNF-a in the HaCaT cells as can be deduced from its increased gelatinolytic activity (Fig 3b) . IL-15, which is upregulated in the epidermis under in£ammatory conditions and which is also able to inhibit apoptosis in keratinocytes, has also no profound e¡ect (Fig 3a) . IL-8 and RANTES, which are both expressed in in£ammatory sites and have powerful chemotactic capabilities, do not in£uence MMP-19 expression at the protein level (Fig 3a,c) .
Concurrently, we have also analyzed whether the bacterial components LPS and LTA in£uence the expression of MMP-19 using immunoblotting. Neither of these seemed to signi¢cantly a¡ect the expression of MMP-19 (Fig 3d) .
Because no obvious up-or downregulation with the compounds studied was observed at the protein level, we also analyzed the regulation of the MMP-19 promoter. As in experiments at the protein level, TNF-a, IL-6, IL-8, and TGF-b did not show any profound e¡ects. Nevertheless, the promoter activity was signi¢cantly upregulated by PMA and downregulated by RA and Dex (Fig 3e) .
MMP-19 is expressed predominantly in the basal layer of healthy epidermis but not in higher epidermal layers with di¡erenti-ating keratinocytes. Because increased calcium concentrations lead to the induction of keratinocyte di¡erentiation, we analyzed the e¡ect of calcium on MMP-19 expression in primary dermal keratinocytes. Nevertheless, neither 0.05 nor 1.2 mM CaCl 2 a¡ected MMP-19 expression in primary subcon£uent keratinocytes. Interestingly, TGF-b, which in the HaCaT cell line did not in£uence MMP-19, clearly upregulated MMP-19 in these primary cells (Fig 4a) .
Furthermore, we investigated whether the expression of MMP-19 is regulated by adhesion to ECM proteins, such as type I and type IV collagens. Plating HaCaT keratinocytes on these collagen matrices or uncoated dishes revealed that the expression of MMP-19 protein and mRNA was signi¢cantly induced by type I collagen, whereas only a weak increase was observed in cells cultured on type IV collagen (Fig 4b^d) . Type I collagen also induced the secretion of MMP-19 as increased amounts of this protein could be immunoprecipitated from radiolabeled keratinocytes (Fig 4b) .
DISCUSSION
Although many MMP can be produced by keratinocytes, only a few of them are expressed constitutively in normal healthy epidermis (Parks et al, 1998 , and publications cited therein). Here we show that MMP-19 is constitutively expressed in the stratum basale and that its staining pattern correlates with that of cytokeratin 14, a marker for undi¡erentiated basal keratinocytes. Such strong constitutive expression is unique among the MMP. Only epilysin (MMP-28), which is phylogenetically the closest MMP to MMP-19, shows a comparable expression in the basal layer although it can be also found in suprabasal layers in the healthy epidermis (Lohi et al, 2001) .
The staining with anti-MMP-19 antibodies also revealed its expression in the outer root sheet of the hair follicle. MMP in the hair follicles have not been extensively studied and there are only fragmentary data on their expression and function in hair follicles and glands in the skin. Nevertheless, MMP-2 and tissue inhibitor of metalloproteinase-1 (TIMP-1) were stained strongly in anagen tissue of the hair follicle (Yamazaki et al, 1999) . MMP-9 was localized to the lower part of the inner root sheath (Henle's layer) of human anagen hair follicles (Jarrousse et al, 2001 ). Jarrousse and colleagues (2001) also postulated that MMP-9 is important for involution of hair follicles.
In the sebaceous glands, undi¡erentiated cells localized to the basement membrane were stained for MMP-19. Why MMP-19 expression is con¢ned to the cells in the vicinity of the basement membrane remains to be elucidated. On the basis of previous studies, it could be postulated that the activity of MMP-19 is required for processing of basement membrane proteins such as laminin, collagen type IV, and tenascin C (Stracke et al, 2000) . In the ecrinne sweat glands, MMP-19 exhibits di¡use expression in the entire duct wall as well as in the basal and luminal layers. Nevertheless, the intensity of the expression varies among the individual glands.
In addition to examining MMP-19 in normal skin, we also investigated MMP-19 expression in skin disorders in which the proliferation and di¡erentiation of keratinocytes is disturbed. In tinea corporis as well as eczema, MMP-19 was expressed not only in the stratum basale, as it is in the healthy epidermis, but its expression also extended to the spinous layers. The staining pattern of MMP-19 correlated with the expression of cytokeratin 14, a marker for basal undi¡erentiated cells.
It has been reported that MMP are also upregulated in psoriasis that is characterized by hyperproliferation of keratinocytes, angiogenesis, and in¢ltration of in£ammatory cells. Whereas MMP-10 and MMP-13 were reported not to be expressed in keratinocytes, MMP-3 was detected in basal keratinocytes. In addition, MMP-12 (metalloelastase) and MMP-9 (gelatinase B) were found in in£ammatory in¢ltrates. Because the expression of these MMP was largely con¢ned to in£ammatory cells, and because TIMP-1 was also abundant, it seems the overexpression of MMP, inhibited by TIMP-1, is unlikely to contribute to psoriatic tissue alterations (Suomela et al, 2001 ). An increase in the expression of gelatinases MMP-2 and MMP-9 in early psoriatic lesions seemed to be accompanied by low levels of TIMP-1 and TIMP-2 (Feliciani et al, 1997) . TIMP-2 and MMP-2 were reported to be expressed in basal and suprabasal keratinocytes. (Fleischmajer et al, 2000) . The unprocessed form of MMP-19, i.e., the form with the propeptide domain, was identi¢ed by the monoclonal antibody CK8/4 in suprabasal and spinous keratinocytes in the ridges as well as irregularly in rete ridges. The anti-pep21 antibodies that recognize the hinge region, i.e., the processed as well as unprocessed forms, revealed a staining corresponding to that one of CK8/4. There were also foci with increased immunoreactivity in the higher spinous layers. This localization of MMP-19 in spinous layers did not correlate with the proliferation marker Ki67 but did correspond to the staining of cytokeratin 6 (not shown) whose expression is upregulated in proliferating keratinocytes or in response to stress stimuli such as wounding. (Mommers et al, 2000; Wojcik et al, 2000) . There was, however, a corresponding staining of Ki 67 and MMP-19 in basal and suprabasal layers in rete ridges. Moreover,TIMP-2, the strongest native inhibitor for MMP-19 was not observed in the higher spinous layers in psoriatic lesions (Fleischmajer et al, 2000) . HaCaT keratinocytes were plated on type I (coll I) and type IV (coll IV) collagen and on uncoated plastic dishes (C). The upregulation was determined at protein (b) and mRNA (c) levels. Expression of MMP-19 was considerably induced by type I collagen, whereas only a weak increase was observed in cells cultured on collagen type IV.WB, western blotting; IP, immunoprecipitation. All immunoblots were stained with the polyclonal a⁄nity-puri¢ed anti-MMP-9 antibodies (Chemicon).
Both anti-MMP-19 antibodies showed comparable staining in basal and suprabasal keratinocytes in the psoriatic lesions. The anti-Pep21 antibodies revealed a slightly more pronounced staining in the upper spinous layers. This variation results most likely from processing of MMP-19 into active forms, which partially di¡use within the ECM and are not identi¢able with the antibody CK8/4.
To examine whether MMP-19 is di¡erentially activated in psoriatic lesions, we compared the expression pattern of MMP-19 using two antibodies recognizing either the propeptide domain (CK8/4) or the hinge region (anti-pep21). Both antibodies used revealed that a band representing the unprocessed glycosylated form of MMP-19 is weaker in psoriatic lesions than in healthy skin. Staining with anti-pep21 antibodies recognizing both the unprocessed and the N-terminally processed forms of MMP-19 clearly showed that the reduced intensity of the band was due to increased processing of this MMP-19 form and that the processed glycosylated form was predominant in the psoriatic lesions. Because MMP-19 showed a distinct expression in the psoriatic lesions, we suggest that MMP-19 contributes to the perpetuation of this disease.
Because in eczema and psoriasis abundant in£ammatory in¢l-trates were found at the a¡ected sites, and because the bacterial and fungal infections trigger diseases such as tinea and folicullitis, we analyzed whether in£ammatory cytokines, chemokines, and bacterial components in£uence the expression of MMP-19 in HaCaT cells. The HaCaT keratinocytes express MMP-19 without additional stimulation and thus resemble basal keratinocytes in vivo. Surprisingly, TNF-a, IL-6, and IL-15 as well as chemokines IL-8 and RANTES did not exhibit any obvious in£uence on the expression of MMP-19 in HaCaT cells. It has already been shown that TNF-a generally initiates the expression of various MMP and we have also seen an increase in the gelatinolytic activity of MMP-9 induced by this cytokine. The constitutive expression of MMP-19 and almost no transcriptional regulation resembles the regulation of MMP-2. In addition, MMP-19 appears to be clearly upregulated by TGF-b at the protein level in primary keratinocytes. Similarly, the transcription of MMP-2 is upregulated by TGF-b, although other MMP are suppressed by this cytokine (Brown et al, 1990; Overall et al, 1991) .
RANTES, which was reported to upregulate MMP-19 in macrophages (Locati et al, 2002) , did not appear to a¡ect the expression of MMP-19 in HaCaT cells. Because bacterial products may also be involved in the regulation of proteolytic enzymes, we tested the e¡ect of LPS and LTA and supernatants from Pseudomonas aeruginosa on MMP-19 expression.
To further support the data on the regulation of MMP-19 in keratinocytes, we have employed the promoter luciferase assay using the MMP-19 promoter containing 1.9 kb of the 5 0 -£anking region. As in immunoblotting, TNF-a, IL-6, and IL-8 did not show any profound e¡ects on the promoter. Furthermore, TGFb, which clearly upregulated MMP-19 expression in primary keratinocytes, did not a¡ect the promoter. This discrepancy could mirror either di¡erences between primary cells and the immortalized HaCaT cell line or di¡erential e¡ects of TGF-b on posttranscriptional events such as stabilization of the mRNA or facilitating its transport and translation into protein (Dodge et al, 1990 , and the references therein).
The promoter activity was signi¢cantly upregulated by PMA. The data on regulation of the MMP-19 promoter with PMA and TGF-b also correspond with data of Impola et al (2003) who analyzed this using real-time quantitative PCR. Interestingly, RA as well as Dex exhibited a profound downregulation of the promoter. RA, vitamins with pleiotropic function, are used to treat psoriasis since they inhibit cellular proliferation and in£amma-tion (Nagpal and Chandraratna, 2000; Kuenzli and Saurat, 2001 ). Thus, MMP-19 in psoriatic lesions would consequently also be inhibited by this treatment. The glucocorticoid Dex is also known to inhibit the expression and activity of other MMP (McGuire-Goldring et al, 1983; Sadowski and Steinmeyer, 2001 ).
In contrast to the cytokines and chemokines tested in this study, the expression of MMP-19 was in£uenced by contact to type I and type IV collagens.Whereas HaCaT keratinocytes plated on type I collagen considerably upregulated the expression of MMP-19, type IV collagen caused only a weak increase of MMP-19. Therefore, it seems that the MMP-19 could be upregulated in response to changes in ECM. Such regulation may play a role in many cutaneous diseases in which keratinocytes are exposed to type I collagen and its fragments that are absent in the intact epidermis.
In summary, MMP-19 appears to have a unique expression pattern in the skin. It is constitutively expressed in basal keratinocytes in healthy skin as well as in HaCaT cells. Its expression extends to the suprabasal and spinous layers in diseased skin. Such an expression pattern correlates with that of cytokeratin 14. Because MMP-19 was found to be coexpressed with cytokeratin 14 throughout the study, it was evident that its expression is associated with the undi¡erentiated basal or proliferating keratinocytes. Moreover, the ratio between unprocessed and processed forms of MMP-19 in psoriatic lesions was skewed to the processed form, which most likely represents an active enzyme. Based on the data reported here, it could be suggested that MMP-19 is involved in propagation of cutaneous diseases and with its capacity to degrade several components of the basement membrane may enable pathogens to cross the disrupted epidermal barrier and disseminate in the host.
